By Counterforce Health Team in Fintepla (fenfluramine) —

How to Get Fintepla (fenfluramine) Covered by Aetna (CVS Health) in Florida: Complete Appeals Guide

Answer Box: Getting Fintepla Covered by Aetna in Florida

Fintepla (fenfluramine) is covered by Aetna CVS Health specialty pharmacy with prior authorization for Dravet syndrome and Lennox-Gastaut syndrome. The fastest path to approval: (1) Enroll in the Fintepla REMS program with baseline echocardiogram, (2) Submit Aetna's prior authorization form with diagnosis documentation and step therapy history, (3) If denied, file internal appeal within 180 days, then external review through Florida's independent review process. Start today: Contact your neurologist to initiate REMS enrollment and gather prior treatment records.

Table of Contents

Coverage Basics

Is Fintepla Covered by Aetna?

Yes, Fintepla is covered under Aetna's specialty pharmacy benefit for FDA-approved indications. However, it requires prior authorization and is not available through retail pharmacies.

Coverage at a Glance:

Requirement Details Source
Prior Authorization Required for all plans Aetna Specialty Drug List
Formulary Status Covered, not on exclusion lists Aetna Exclusion Lists
Step Therapy May apply depending on plan Plan-specific requirements
Site of Care Specialty pharmacy only CVS Specialty dispensing
REMS Program Mandatory enrollment FDA REMS Requirements

Which Aetna Plans Cover Fintepla?

Most Aetna commercial plans include specialty drug coverage, but specific requirements vary by plan type and employer contracts. Check your plan's drug formulary or call the member services number on your insurance card.

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. REMS Enrollment (Patient & Prescriber)
  2. Gather Documentation
    • Diagnosis confirmation (Dravet or LGS)
    • Prior antiepileptic drug trials and outcomes
    • Current seizure frequency and severity
    • Timeline: 1-3 days
  3. Submit Prior Authorization
    • Provider submits via Aetna portal or fax
    • Include all REMS documentation
    • Timeline: Same day submission
  4. Aetna Review
    • Standard review: 30-45 days
    • Expedited review: 72 hours (if urgent)
  5. If Approved
    • CVS Specialty contacts patient
    • Medication shipped within 1-2 business days

Clinician Corner: Medical Necessity Letter

Your neurologist should include these key elements:

  • Diagnosis: Clear documentation of Dravet syndrome or Lennox-Gastaut syndrome with supporting evidence (genetic testing for Dravet, EEG findings for LGS)
  • Prior Treatments: Detailed history of antiepileptic drugs tried, doses, duration, and reasons for discontinuation
  • Clinical Rationale: Why Fintepla is medically necessary based on FDA labeling and current seizure control
  • Safety Monitoring: Plan for required echocardiograms and REMS compliance

REMS Requirements

Mandatory Safety Program

The Fintepla REMS program is required due to risks of heart valve problems and pulmonary hypertension. Both patients and prescribers must be enrolled before treatment can begin.

Key Requirements:

  • Baseline Echocardiogram: Required before starting treatment
  • Ongoing Monitoring: Echocardiograms every 6 months during treatment
  • Post-Treatment Echo: Required 3-6 months after stopping Fintepla
  • Documentation: All echo results must be submitted to REMS
Tip: Some patients may qualify for at-home echocardiogram services through the REMS program. Contact Fintepla REMS support to inquire about eligibility.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
Missing REMS enrollment Submit proof of enrollment REMS Patient Enrollment Form, baseline echo
Diagnosis not supported Provide diagnostic evidence Genetic testing (Dravet), EEG reports (LGS)
Step therapy not met Document prior failures Detailed medication history with outcomes
Not medically necessary Submit clinical justification Medical necessity letter from neurologist
Drug interactions Address safety concerns Medication reconciliation, monitoring plan

Appeals Process in Florida

Internal Appeals

If your Fintepla prior authorization is denied, you have 180 days to file an internal appeal with Aetna.

How to Appeal:

  1. Call Aetna member services (number on your insurance card)
  2. Request appeal forms or submit online through member portal
  3. Include additional documentation supporting medical necessity
  4. Timeline: 7-14 business days for standard appeals, 72 hours for urgent

External Review

After exhausting internal appeals, Florida residents can request an independent external review for denials based on medical necessity.

External Review Process:

  • Must be requested after final internal denial
  • Available for denials exceeding $500
  • Conducted by Independent Review Organizations
  • Timeline: 30 days (72 hours if expedited)
  • No cost to patient
Note: External review decisions are final and binding on both Aetna and the member.

Counterforce Health helps patients navigate complex insurance appeals by analyzing denial letters and crafting evidence-backed responses that align with payer policies. Their platform identifies specific denial reasons and generates targeted rebuttals using FDA labeling, clinical guidelines, and peer-reviewed studies. For families dealing with rare epilepsy syndromes like Dravet or LGS, Counterforce Health can streamline the appeals process and improve approval rates.

Costs & Financial Assistance

Typical Costs

  • Cash Price: Approximately $1,595 for a 30-mL bottle (varies by dose)
  • Insurance Copay: Depends on plan design and specialty tier

Financial Assistance Options

  • Manufacturer Support: Contact UCB for patient assistance programs
  • CVS Specialty CareTeam: Can help identify copay assistance options
  • Foundation Grants: Epilepsy Foundation and other rare disease organizations may offer support

Specialty Pharmacy Requirements

Why CVS Specialty?

Fintepla must be dispensed through a REMS-certified specialty pharmacy. CVS Specialty is Aetna's preferred specialty pharmacy partner.

What to Expect:

  • Pharmacy will contact you after approval
  • Clinical consultation before first shipment
  • Ongoing adherence monitoring and support
  • Coordination with REMS requirements

Timeline Expectations

Complete Process Timeline:

REMS Enrollment → PA Submission → Aetna Review → Approval → Dispensing
    1-2 weeks        Same day       30-45 days    1-2 days    1-2 days

If Appeals Are Needed:

  • Internal Appeal: Add 7-14 days
  • External Review: Add 30 days
  • Total potential timeline: 2-4 months

When to Escalate

Contact Florida Insurance Regulators

If you encounter problems with Aetna's appeals process, contact:

Florida Department of Financial Services

  • Insurance Consumer Helpline: 1-877-693-5236
  • Online complaint filing
  • Consumer specialists can facilitate communication with insurers

When to File a Complaint

  • Missed appeal deadlines by Aetna
  • Failure to follow proper appeal procedures
  • Unreasonable delays in processing

Frequently Asked Questions

How long does Aetna prior authorization take for Fintepla in Florida? Standard prior authorization takes 30-45 days. Expedited reviews for urgent cases are completed within 72 hours.

What if Fintepla is not on my Aetna formulary? You can request a formulary exception with documentation of medical necessity and prior treatment failures.

Can I request an expedited appeal? Yes, if delays could seriously jeopardize your health. Your doctor must support the urgency request.

Does step therapy apply if I've tried medications outside Florida? Yes, prior treatment history from any location should be documented and submitted with your prior authorization.

What happens if my appeal is denied? You can request external review through Florida's independent review process, which provides a final, binding decision.

How often do I need to renew Fintepla authorization? Most specialty drug authorizations require annual renewal with updated clinical documentation.

From Our Advocates

We've seen families successfully appeal Fintepla denials by providing comprehensive REMS documentation and detailed seizure logs showing inadequate control with standard therapies. The key is demonstrating both medical necessity and safety monitoring compliance. While outcomes vary by individual circumstances, thorough preparation significantly improves approval chances.

When navigating insurance coverage for rare epilepsy treatments, having expert support can make the difference between approval and denial. Counterforce Health specializes in turning insurance denials into successful appeals by identifying specific policy requirements and crafting evidence-based responses that speak directly to payer criteria.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage and appeal processes may vary by individual plan and circumstances. Always consult with your healthcare provider and insurance company for personalized guidance. For assistance with insurance appeals and coverage issues in Florida, contact the Florida Department of Financial Services Consumer Helpline at 1-877-693-5236.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.